Table 5. Comparison of the characteristics between bacterial non-carriers and carriers in blood.
Variable | Bacterial non-carrier in blood (n = 11) | Bacterial carrier in blood (n = 19) | P value |
---|---|---|---|
Age (y) | 68.4±8.2 | 67.5±5.7 | 0.74 |
Male sex | 9 (82) | 19 (100) | 0.13 |
BMIa (kg/m2) | 25.3±4.2 | 23.8±4.4 | 0.37 |
Smoking | 11 (100) | 18 (95) | 1 |
Hypertension | 8 (73) | 11 (58) | 0.47 |
Diabetes | 2 (18) | 5 (26) | 1 |
Aneurysm diameter (mm) | 45.4±5.0 | 56.1±10.6 | 0.004 |
Thrombus thickness (mm) | 12.4±9.3 | 13.9±8.9 | 0.67 |
Intraluminal thrombus volume (%) | 33.8±25.3 | 40.2±23.8 | 0.50 |
Medication | |||
PPIb/H2 blockerc | 4 (36) | 5 (26) | 0.69 |
Statin | 7 (64) | 11 (58) | 1 |
Intestinal drug | 2 (18) | 1 (5) | 0.54 |
Differential count of leukocytes | |||
Neutrophils (%) | 56.8±6.4 | 63.3±9.4 | 0.03 |
Lymphocytes (%) | 30.6±6.0 | 25.2±7.4 | 0.04 |
Monocytes (%) | 5.3±0.9 | 6.4±1.5 | 0.02 |
NLR d | 1.96±0.61 | 2.94±1.77 | 0.04 |
LMR e | 5.86±1.38 | 4.02±1.25 | <0.01 |
Data are presented as the mean ± standard error or number (%).
aBMI; body mass index.
bPPI; proton pomp inhibitor.
cH2 blocker; histamine H2-receptor antagonist.
dNLR; neutrophil-to-lymphocyte ratio.
eLMR; lymphocyte-to-monocyte ratio.